136 related articles for article (PubMed ID: 38314285)
1. SYT7 (synaptotagmin 7) promotes cervical squamous cell carcinoma.
Huang J; Xu W; Huang Q; Chen E; Chen J
Heliyon; 2024 Feb; 10(3):e24806. PubMed ID: 38314285
[TBL] [Abstract][Full Text] [Related]
2. Silencing of synaptotagmin 7 regulates osteosarcoma cell proliferation, apoptosis, and migration.
Wu Z; Sun Z; Huang R; Zang D; Wang C; Yan X; Yan W
Histol Histopathol; 2020 Mar; 35(3):303-312. PubMed ID: 31631310
[TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin 7 in twist-related protein 1-mediated epithelial - Mesenchymal transition of non-small cell lung cancer.
Liu X; Li C; Yang Y; Liu X; Li R; Zhang M; Yin Y; Qu Y
EBioMedicine; 2019 Aug; 46():42-53. PubMed ID: 31395502
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis.
Xiao B; Li J; Fan Y; Ye M; Lv S; Xu B; Chai Y; Zhou Z; Wu M; Zhu X
Mol Med Rep; 2017 Dec; 16(6):9017-9022. PubMed ID: 28990113
[TBL] [Abstract][Full Text] [Related]
5. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
[TBL] [Abstract][Full Text] [Related]
6. Synaptotagmin7 Is Overexpressed In Colorectal Cancer And Regulates Colorectal Cancer Cell Proliferation.
Wang K; Xiao H; Zhang J; Zhu D
J Cancer; 2018; 9(13):2349-2356. PubMed ID: 30026831
[No Abstract] [Full Text] [Related]
7. LncRNA HOXD-AS1 affects proliferation and apoptosis of cervical cancer cells by promoting FRRS1 expression via transcription factor ELF1.
Liu H; Liu L; Liu Q; He F; Zhu H
Cell Cycle; 2022 Feb; 21(4):416-426. PubMed ID: 34985386
[TBL] [Abstract][Full Text] [Related]
8. SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC.
Fu Y; Tian G; Zhang Z; Yang X
Cancer Cell Int; 2021 Dec; 21(1):696. PubMed ID: 34930262
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR-1305/helicase, lymphoid specific (HELLS) axis.
He C; Liu L
Bioengineered; 2022 Apr; 13(4):8311-8322. PubMed ID: 35311456
[TBL] [Abstract][Full Text] [Related]
10. SYT7 is a key player in increasing exosome secretion and promoting angiogenesis in non-small-cell lung cancer.
Liu X; Li R; Chen X; Yao J; Wang Q; Zhang J; Jiang Y; Qu Y
Cancer Lett; 2023 Nov; 577():216400. PubMed ID: 37774826
[TBL] [Abstract][Full Text] [Related]
11. SYT7 plays a role in promoting thyroid cancer by mediating HMGB3 ubiquitination.
Dong S; Pan J; Shen YB; Zhu LX; Chen L; Zhu F; Li H; Shen HX; Xia Q; Wu YJ; Xie XJ
Endocr Relat Cancer; 2022 Mar; 29(4):175-189. PubMed ID: 35073278
[TBL] [Abstract][Full Text] [Related]
12. SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1.
Zhang W; Long J; Tang P; Chen K; Guo G; Yu Z; Lin J; Liu L; Zhan R; Xu Z
Biomark Res; 2023 Jun; 11(1):58. PubMed ID: 37280656
[TBL] [Abstract][Full Text] [Related]
13. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
Kanda M; Tanaka H; Shimizu D; Miwa T; Umeda S; Tanaka C; Kobayashi D; Hattori N; Suenaga M; Hayashi M; Iwata N; Yamada S; Fujiwara M; Kodera Y
Oncogene; 2018 Sep; 37(39):5355-5366. PubMed ID: 29858600
[TBL] [Abstract][Full Text] [Related]
14. BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.
Song J; Xu F; An L; Yin Y; Liu J; Chai J; Yang Y; Li M; Jia Q; Wang Z
Pathol Res Pract; 2023 Jul; 247():154577. PubMed ID: 37257243
[TBL] [Abstract][Full Text] [Related]
15. ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma.
Jia Q; Song J; Xu T; Liu J; Chai J; Yang Y; Li L; Li M; Yang X
Pathol Res Pract; 2023 Jan; 241():154268. PubMed ID: 36495760
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.
Huang Y; Wu Q; Tan X
Bioengineered; 2022 Mar; 13(3):6955-6965. PubMed ID: 35249447
[TBL] [Abstract][Full Text] [Related]
17. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
[TBL] [Abstract][Full Text] [Related]
18. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3B is overexpressed in cervical cancer and promotes the proliferation of cervical cancer cells through apoptosis, cell cycle, and p53 pathway.
Wei Z; Gan J; Feng X; Zhang M; Chen Z; Zhao H; Du Y
Front Oncol; 2022; 12():864889. PubMed ID: 36249021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
